DD123329A5 - - Google Patents
Info
- Publication number
- DD123329A5 DD123329A5 DD190370A DD19037075A DD123329A5 DD 123329 A5 DD123329 A5 DD 123329A5 DD 190370 A DD190370 A DD 190370A DD 19037075 A DD19037075 A DD 19037075A DD 123329 A5 DD123329 A5 DD 123329A5
- Authority
- DD
- German Democratic Republic
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19742461312 DE2461312A1 (de) | 1974-12-23 | 1974-12-23 | D-homo-20-keto-pregnane und verfahren zu ihrer herstellung |
| DE19752506688 DE2506688A1 (de) | 1975-02-14 | 1975-02-14 | D-homo-19-nor-20-ketopregnane und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD123329A5 true DD123329A5 (fr) | 1976-12-12 |
Family
ID=25768157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD190370A DD123329A5 (fr) | 1974-12-23 | 1975-12-19 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4056633A (fr) |
| JP (1) | JPS5188953A (fr) |
| AU (1) | AU501685B2 (fr) |
| CA (1) | CA1051868A (fr) |
| DD (1) | DD123329A5 (fr) |
| DK (1) | DK138501C (fr) |
| ES (1) | ES443825A1 (fr) |
| FR (1) | FR2295739A1 (fr) |
| GB (1) | GB1538869A (fr) |
| IL (1) | IL48628A0 (fr) |
| LU (1) | LU74087A1 (fr) |
| NL (1) | NL7514976A (fr) |
| SE (1) | SE7514514L (fr) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4104306A (en) * | 1976-05-05 | 1978-08-01 | Abbott Laboratories | 12A-Deoxy chelocardin |
| US5439900A (en) * | 1993-02-25 | 1995-08-08 | Bukusoglu; Cuneyt | Methods and compositions for providing analgesia and enhanced anesthesia |
| US20040034215A1 (en) * | 2002-08-16 | 2004-02-19 | White Michael J. | 5-Androsten-3beta-ol steroid intermediates and processes for their preparation |
| US20070066579A1 (en) * | 2002-08-16 | 2007-03-22 | White Michael J | 5-androsten-3beta-ol steroid intermediates and processs for their preparation |
| EP2986624B1 (fr) | 2013-04-17 | 2020-03-25 | Sage Therapeutics, Inc. | Stéroïdes neuroactifs 19-nor et pour l'utilisation thérapeutique |
| US20160068563A1 (en) | 2013-04-17 | 2016-03-10 | Boyd L. Harrison | 19-nor neuroactive steroids and methods of use thereof |
| US9725481B2 (en) | 2013-04-17 | 2017-08-08 | Sage Therapeutics, Inc. | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof |
| KR102396328B1 (ko) | 2013-04-17 | 2022-05-10 | 세이지 테라퓨틱스, 인크. | 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법 |
| SI3021852T1 (sl) | 2013-07-19 | 2021-07-30 | Sage Therapeutics, Inc. | Nevroaktivni steroidi, sestavki in uporabe le-teh |
| AU2014308621C1 (en) | 2013-08-23 | 2022-01-06 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| ME03809B (fr) | 2014-10-16 | 2021-04-20 | Sage Therapeutics Inc | Compositions et méthodes pour traiter des troubles du snc |
| CN117024501A (zh) | 2014-10-16 | 2023-11-10 | 萨奇治疗股份有限公司 | 靶向cns障碍的组合物和方法 |
| WO2016082789A1 (fr) | 2014-11-27 | 2016-06-02 | Sage Therapeutics, Inc. | Compositions et procédés pour traiter des troubles du snc |
| RS61530B1 (sr) | 2015-01-26 | 2021-04-29 | Sage Therapeutics Inc | Kompozicije i postupci za lečenje poremećaja cns |
| EP4155314A1 (fr) | 2015-02-20 | 2023-03-29 | Sage Therapeutics, Inc. | Stéroïdes neuroactifs, compositions et leurs utilisations |
| WO2018013615A1 (fr) | 2016-07-11 | 2018-01-18 | Sage Therapeutics, Inc. | Stéroïdes neuroactifs substitués en c7, c12 et c16 et méthodes d'utilisation associées |
| MA45599A (fr) | 2016-07-11 | 2019-05-15 | Sage Therapeutics Inc | Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation |
| BR112020012761A2 (pt) * | 2017-12-22 | 2021-02-17 | Sage Therapeutics, Inc. | composições e métodos para o tratamento de distúrbios do snc |
| TW201930269A (zh) * | 2018-01-12 | 2019-08-01 | 美商賽吉醫療公司 | 用於治療cns病症之組合物及方法 |
| KR20250174100A (ko) | 2018-12-05 | 2025-12-11 | 세이지 테라퓨틱스, 인크. | 신경활성 스테로이드 및 이의 사용 방법 |
| CN115651054B (zh) * | 2019-01-08 | 2024-06-21 | 成都康弘药业集团股份有限公司 | 甾体类化合物、用途及其制备方法 |
| SG11202112391UA (en) | 2019-05-31 | 2021-12-30 | Sage Therapeutics Inc | Neuroactive steroids and compositions thereof |
| JP7754725B2 (ja) * | 2019-06-27 | 2025-10-15 | セージ セラピューティクス， インコーポレイテッド | Ｃｎｓ障害を治療するための組成物及び方法 |
| CN114729000A (zh) * | 2019-06-27 | 2022-07-08 | 萨奇治疗股份有限公司 | 用于治疗cns病症的化合物 |
| CA3143509A1 (fr) | 2019-06-27 | 2020-12-30 | Sage Therapeutics, Inc. | Compositions et methodes de traitement de troubles du snc |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3876705A (en) * | 1972-06-12 | 1975-04-08 | Univ New Brunswick | Steroid total synthesis and intermediates |
-
1975
- 1975-12-09 IL IL48628A patent/IL48628A0/xx unknown
- 1975-12-17 US US05/641,602 patent/US4056633A/en not_active Expired - Lifetime
- 1975-12-17 AU AU87637/75A patent/AU501685B2/en not_active Expired
- 1975-12-19 DD DD190370A patent/DD123329A5/xx unknown
- 1975-12-22 SE SE7514514A patent/SE7514514L/xx unknown
- 1975-12-22 LU LU74087A patent/LU74087A1/xx unknown
- 1975-12-22 GB GB52351/75A patent/GB1538869A/en not_active Expired
- 1975-12-23 DK DK588775A patent/DK138501C/da active
- 1975-12-23 NL NL7514976A patent/NL7514976A/xx not_active Application Discontinuation
- 1975-12-23 JP JP50153888A patent/JPS5188953A/ja active Pending
- 1975-12-23 CA CA242,439A patent/CA1051868A/fr not_active Expired
- 1975-12-23 FR FR7539458A patent/FR2295739A1/fr not_active Withdrawn
- 1975-12-23 ES ES443825A patent/ES443825A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK138501B (da) | 1978-09-18 |
| DK138501C (da) | 1979-02-19 |
| AU501685B2 (en) | 1979-06-28 |
| FR2295739A1 (fr) | 1976-07-23 |
| ES443825A1 (es) | 1977-05-01 |
| JPS5188953A (en) | 1976-08-04 |
| IL48628A0 (en) | 1976-02-29 |
| AU8763775A (en) | 1977-06-23 |
| LU74087A1 (fr) | 1976-07-20 |
| US4056633A (en) | 1977-11-01 |
| DK588775A (da) | 1976-06-24 |
| GB1538869A (en) | 1979-01-24 |
| NL7514976A (nl) | 1976-06-25 |
| SE7514514L (sv) | 1976-06-24 |
| CA1051868A (fr) | 1979-04-03 |